The fallout for Venture Global Inc., in the wake of a troubled initial public offering, accelerated amid a market selloff ...

HistoSonics Inc., a medical device company whose backers include Johnson & Johnson’s venture capital arm, is weighing a US ...

Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial ...

Even so the deal solidifies Venture Global’s place in the public markets with an impressive $50 billion market cap. And it ...

Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.

The IPO trend remains robust in 2025, driven by strong retail investor interest and a shift from FPIs to the primary market.

Domestic investors will be reacting to Q3 results from several companies, including Tata Steel, Bajaj Housing Finance, Coal ...

The listing was a book-built IPO and comprised a fresh issuance of 7.5 million shares. The price band for the issue was Rs ...

Learn about Karman Holdings' upcoming $100 million US IPO, their focus on missile and space systems, and the financial ...

Rexpro Enterprises IPO shows a grey market premium of ₹10, indicating a potential listing price of ₹155. The IPO was ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...

Eyecare provider Dr Agarwal's Health Care Ltd.'s Rs 3,027.3-crore initial public offering is scheduled to open on Wednesday.